MedKoo Cat#: 413929 | Name: Drocinonide

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Drocinonide is an Anti-Inflammatory

Chemical Structure

Drocinonide
Drocinonide
CAS# 2355-59-1

Theoretical Analysis

MedKoo Cat#: 413929

Name: Drocinonide

CAS#: 2355-59-1

Chemical Formula: C24H35FO6

Exact Mass: 438.2418

Molecular Weight: 438.54

Elemental Analysis: C, 65.73; H, 8.04; F, 4.33; O, 21.89

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Drocinonide; Drocinonidum; Drocinonida
IUPAC/Chemical Name
Pregnane-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (5alpha,11beta,16alpha)-
InChi Key
GZBONOYGBJSTHF-BGMQTHILSA-N
InChi Code
InChI=1S/C24H35FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h13,15-17,19,26,28H,5-12H2,1-4H3/t13-,15-,16-,17-,19-,21-,22-,23-,24+/m0/s1
SMILES Code
C[C@@]12[C@@]3(C(CO)=O)[C@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])CC[C@@]5([H])CC(CC[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 438.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: McGinity JW, Brown RL. Stabilizing effect of inorganic phosphate salts on antibiotic-steroid ophthalmic preparations. J Pharm Sci. 1975 Sep;64(9):1528-30. doi: 10.1002/jps.2600640923. PMID: 1185572. 2: Liu X, Li SK, Jeong EK. Ocular pharmacokinetic study of a corticosteroid by 19F MR. Exp Eye Res. 2010 Sep;91(3):347-52. doi: 10.1016/j.exer.2010.05.022. Epub 2010 Jun 9. PMID: 20537996; PMCID: PMC2938785. 3: Suarez S, Gonzalez-Rothi RJ, Schreier H, Hochhaus G. Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm Res. 1998 Mar;15(3):461-5. doi: 10.1023/a:1011936617625. PMID: 9563078. 4: Gonzalez-Rothi RJ, Suarez S, Hochhaus G, Schreier H, Lukyanov A, Derendorf H, Costa TD. Pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm Res. 1996 Nov;13(11):1699-703. doi: 10.1023/a:1016448908909. PMID: 8956337. 5: Roy RR, Gardiner PF, Simpson DR, Edgerton VR. Glucocorticoid-induced atrophy in different fibre types of selected rat jaw and hind-limb muscles. Arch Oral Biol. 1983;28(7):639-43. doi: 10.1016/0003-9969(83)90012-2. PMID: 6579895.